Omnicell, Inc. (OMCL) Tops Q3 EPS by 1c, Sales Top Expectations
Tweet
Share
E-mailGet Alerts OMCL Hot Sheet
Price: $37.30 -0.9%
Financial Fact:
Research and development: 15.26M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 15.26M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Omnicell, Inc. (NASDAQ: OMCL) reported Q3 EPS of $0.16, $0.01 better than the analyst estimate of $0.15. Revenue for the quarter came in at $64.4 million versus the consensus estimate of $62.5 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. Physical Therapy names Nchacha Etta as CFO, effective Sept. 2026
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
